The global market for Contrast Media is projected to reach US$5.3 billion by 2025 – GlobeNewswire

September 03, 2020 15:05 ET | Source: ReportLinker

New York, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Contrast Media Industry" - https://www.reportlinker.com/p05798259/?utm_source=GNW The global burden of chronic diseases can be put into perspective by the fact that it is the leading cause of death and disability in the world. Although easily preventable, chronic diseases such as heart disease, stroke, cancer, type-2 diabetes, obesity, thyroidism, and arthritis push up healthcare costs and also demand for healthcare services. By 2030, chronic diseases will emerge to be the most costly and prevalent killer worldwide. As a result, healthcare spending is forecast to reach a mind-bending US$19 trillion by the year 2040. A major portion of this expenditure will be spent on medical imaging procedures such as X-Rays, CT scan (computed tomography scan), MRI (magnetic resonance imaging), ultrasound, and nuclear medicine imaging, including positron-emission tomography (PET), among other emerging hybrid imaging technologies. As an extremely important aspect of medical practice, imaging has and still continues to revolutionize the world of healthcare. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily treated and of late has been assuming even greater importance as the world healthcare migrates to the tenets of preventative care. Better diagnosis has a direct and a positive impact on therapy procedures and treatment planning. The rise of imaging based surgical strategies to safely handle complicated surgeries is also helping push up the importance of medical imaging.

A key element of the ongoing healthcare reforms and the migration to value based care is medical imaging. Technologies such as nuclear medicine (imaging), molecular imaging, and contrast enhanced radiology procedures are benefiting significantly for the simple reason that there can be no value based care without value based imaging activities. Medical imaging remains very crucial in healthcare as it plays a decisive role in enabling low-cost effective patient care. The starting point for effective treatment is high-performance imaging and accurate diagnosis. Replacing low-value imaging with high performance imaging reduces costs and enhances effectiveness of treatment. In this regard, contrast enhanced imaging and the benefits offered are a perfect value creation. Contrast agents help in advanced visualization of biological structures; and helps capture hard-to-image anatomical regions. They help eliminate errors caused by radiologists perception which tends to influence interpretation of the true structure of the underlying anatomy. Oral, intravenous, rectal, and intrathecal contrast agents are indispensable today in the practice of radiology for their most primary benefit which is enhanced visibility of internal structures. Efficiency of contrast media over the years have evolved from high-osmolar contrast media (HOCM) which have limited utility and higher side-effects to low-osmolality contrast agents. The development of nonionic compounds marked a major step forward. The most recent type of contrast agent developed is the iso-osmolar contrast media (IOCM) which is composed of dimers, a molecule with two benzene rings and 3 iodine atoms. The United States and Europe represent large markets worldwide with a combined share of 66.9% of the market. China ranks as the fastest growing market with a CAGR of 5% over the analysis period supported by the remarkable progress made by the country in developing its primary health-care system. Access to and affordability of healthcare services have improved significantly over the last decade. Improving access to timely care is helping drive demand for imaging services in the country.

Read the full report: https://www.reportlinker.com/p05798259/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Prevalence of Chronic Diseases Among the Growing Global Population Pushes Up the Diagnostic Burden & Demand for Imaging Rising Prevalence of Chronic Diseases Amplifies the Volume of Imaging Procedures, Driving Opportunities for Imaging Agents: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030 The US$ 37 Billion Robustly Growing Medical Imaging Market Provides Lucrative Opportunities for Contrast Agents for Advanced Visualization: Global Medical Imaging Market (In US$ Billion) for the Years 2018, 2020 and 2022 Aging Population, a Demographic Catalyst Driving Demand for Imaging Services Rapidly Aging Population & the Challenges Associated With Geriatric Imaging Spurs Demand for Contrast Imaging Agents: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025 Rise of Nuclear Medicine, the Cornerstone for the Growth for Radioactive Tracers Improving Quality & Value of Nuclear Medicine Bodes Well for Radioactive Contrast Agents: Global Market for Nuclear Imaging (US$ Billion) for the Years 2018, 2020, 2022 and 2025 by Type Short Supply of Technetium-99m Threatens to Impact Nuclear Imaging Services Plagued by the Risk of Reactor Decommissioning & Unplanned Maintenance Shutdowns, Fragile Supply of Mo-99 Will Remain a Cause for Concern: Global Mo-99 Production Capacity (In Curies (Ci) Per Week) by Producer for the Years 2016 through 2022 Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS AMAG Pharmaceuticals, Inc. (USA) Bayer Healthcare LLC (USA) Bracco Imaging SpA (Italy) GE Healthcare (USA) Genovis AB (Sweden) Guerbet Group (France) J.B. Chemicals & Pharmaceuticals Ltd. (India) Jodas Expoim (India) Lantheus Medical Imaging, Inc. (USA) Magnus Health (India) Medtronic Plc. (Ireland) nanoPET Pharma GmbH (Germany) Sanochemia Pharmazeutika AG (Austria) Spago Nanomedical AB (Sweden) Taejoon Pharm Co., Ltd. (South Korea) Unijules Life Sciences Ltd. (India)

3. MARKET TRENDS & DRIVERS Migration to Value Based Care Throws the Focus on Quality & Value of Imaging & Its Ability to Improve Patient Care by Providing Better Quality Images With ?Value? being the new Currency in Healthcare Markets Worldwide, Value Based Imaging Will Positively Impact Contrast Enhanced Imaging Procedures: % of Value-Based Reimbursement (VBR) & Fee-For-Service Structured Healthcare Organizations for the Years 2016, 2018 and 2022 Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI Commercially Available MRI Contrast Agents Spurred by Safety & Efficiency Benefits, Growing MRI Procedures & Parallel Increase in MRI Machines to Benefit Demand for MRI Contrast Agents: Global MRI Equipment Market (In US$ Billion) for the Years 2018, 2020, 2022 and 2024 Equipment Density Correlates With Number of Imaging Procedures: Magnetic Resonance Imaging (MRI) Units in Select Countries: (Per Million Population) for the Year 2019 Evolving Clinical Applications of Contrast-Enhanced Ultrasound (CEUS) Drive Demand for Ultrasound Contrast Agents Clinically Available Ultrasound Contrast Agents Growing Use of CEUS in Emergency and Critical Care Special Focus on Microbubble Contrast Agents for Ultrasound Imaging Clinical Applications of Microbubbles Oscillating Microbubbles: To Revolutionize Ultrasound Growing Market for Ultrasound Equipment Pushes Up the Number of CEUS Procedures Performed: Global Market for Ultrasound Equipment (In US Billion) for the Years 2017, 2019, 2022 and 2024 Continued Value of CT Imaging in Cardiology Despite Risk of Radiation Exposure Drives Demand for Contrast-Enhanced CT Contrast Agents Used in CT Imaging by Class: A Snapshot CCTA Gaining Traction in Coronary Arteries Imaging List of Iodine-Containing Contrast Agents for Coronary CT Angiography Growing Access to CT Imaging Bodes Well for CT Contrast Agents: Density of CT Scanners in Select Countries (Per Million Population) for the Year 2019 Rise in Image Guided Surgeries Drives Demand for Contrast Agents Emergence of Molecular-Targeted Fluorescent Tracers Select Potential ?always-on? Targeted Tracers for Fluorescence Image-Guided Surgery (FIGS) The Use of Gold Nanoclusters as Contrast Agent for IGS of Head and Neck Tumors Better Surgical Outcome Drives the Number of Image Guided Surgeries Performed Worldwide Along with Demand for Contrast Agents: Global Market for Image Guided Surgical Devices (In US$ Billion) for the Years 2018, 2020, and 2022 by Imaging Type Stringent Guidelines & Implementation of Best Practices for Safe Use of Contrast Agents to Encourage Patient Acceptance of Contrast Enhanced Imaging Safety Issues with Iodinated Agents, Gadolinium BCA and Microbubbles Symptoms of Reaction to Administration of Iodinated Contrast Media Agents Innovations Remain Crucial to Growth A Review of Advancements in Contrast Media Injector Technology Development of New Contrast Agents Key Challenges Confront the Market Advances in Imaging Technology Reduce Contrast Media Use Product Recalls and Side Effects of Contrast Media Challenge Growth A Snapshot of Side Effects, Allergic and Adverse Reactions with Contrast Agents

4. GLOBAL MARKET PERSPECTIVE Table 1: Contrast Media Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 2: Contrast Media Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019

Table 3: Contrast Media Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: X-ray/Computed Tomography (CT) (Imaging Modality) World Market by Region/Country in US$ Thousand: 2020 to 2027

Table 5: X-ray/Computed Tomography (CT) (Imaging Modality) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019

Table 6: X-ray/Computed Tomography (CT) (Imaging Modality) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Magnetic Resonance Imaging (MRI) (Imaging Modality) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027

Table 8: Magnetic Resonance Imaging (MRI) (Imaging Modality) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019

Table 9: Magnetic Resonance Imaging (MRI) (Imaging Modality) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Ultrasound (Imaging Modality) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027

Table 11: Ultrasound (Imaging Modality) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019

Table 12: Ultrasound (Imaging Modality) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Barium-based Contrast Media (Type of Media) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027

Table 14: Barium-based Contrast Media (Type of Media) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019

Table 15: Barium-based Contrast Media (Type of Media) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 16: Iodinated Contrast Media (Type of Media) World Market by Region/Country in US$ Thousand: 2020 to 2027

Table 17: Iodinated Contrast Media (Type of Media) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019

Table 18: Iodinated Contrast Media (Type of Media) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 19: Gadolinium-based Contrast Media (Type of Media) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027

Table 20: Gadolinium-based Contrast Media (Type of Media) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2012 to 2019

Table 21: Gadolinium-based Contrast Media (Type of Media) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027

Table 22: Microbubble Contrast Media (Type of Media) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027

Table 23: Microbubble Contrast Media (Type of Media) Global Historic Demand in US$ Thousand by Region/Country: 2012 to 2019

Table 24: Microbubble Contrast Media (Type of Media) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 25: Radiology (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027

Table 26: Radiology (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019

Table 27: Radiology (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

Table 28: Interventional Radiology (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 29: Interventional Radiology (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019

Table 30: Interventional Radiology (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

Table 31: Interventional Cardiology (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027

Table 32: Interventional Cardiology (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019

Table 33: Interventional Cardiology (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES Table 34: United States Contrast Media Market Estimates and Projections in US$ Thousand by Imaging Modality: 2020 to 2027

Table 35: Contrast Media Market in the United States by Imaging Modality: A Historic Review in US$ Thousand for 2012-2019

Table 36: United States Contrast Media Market Share Breakdown by Imaging Modality: 2012 VS 2020 VS 2027

Table 37: United States Contrast Media Market Estimates and Projections in US$ Thousand by Type of Media: 2020 to 2027

Table 38: Contrast Media Market in the United States by Type of Media: A Historic Review in US$ Thousand for 2012-2019

Table 39: United States Contrast Media Market Share Breakdown by Type of Media: 2012 VS 2020 VS 2027

Table 40: United States Contrast Media Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027

Table 41: Contrast Media Historic Demand Patterns in the United States by Application in US$ Thousand for 2012-2019

Table 42: Contrast Media Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027

CANADA Table 43: Canadian Contrast Media Market Estimates and Forecasts in US$ Thousand by Imaging Modality: 2020 to 2027

Table 44: Canadian Contrast Media Historic Market Review by Imaging Modality in US$ Thousand: 2012-2019

Table 45: Contrast Media Market in Canada: Percentage Share Breakdown of Sales by Imaging Modality for 2012, 2020, and 2027

Table 46: Canadian Contrast Media Market Estimates and Forecasts in US$ Thousand by Type of Media: 2020 to 2027

Table 47: Canadian Contrast Media Historic Market Review by Type of Media in US$ Thousand: 2012-2019

Table 48: Contrast Media Market in Canada: Percentage Share Breakdown of Sales by Type of Media for 2012, 2020, and 2027

Table 49: Canadian Contrast Media Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027

Table 50: Contrast Media Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2012-2019

Table 51: Canadian Contrast Media Market Share Analysis by Application: 2012 VS 2020 VS 2027

JAPAN Table 52: Japanese Market for Contrast Media: Annual Sales Estimates and Projections in US$ Thousand by Imaging Modality for the Period 2020-2027

Table 53: Contrast Media Market in Japan: Historic Sales Analysis in US$ Thousand by Imaging Modality for the Period 2012-2019

Table 54: Japanese Contrast Media Market Share Analysis by Imaging Modality: 2012 VS 2020 VS 2027

Table 55: Japanese Market for Contrast Media: Annual Sales Estimates and Projections in US$ Thousand by Type of Media for the Period 2020-2027

Table 56: Contrast Media Market in Japan: Historic Sales Analysis in US$ Thousand by Type of Media for the Period 2012-2019

Table 57: Japanese Contrast Media Market Share Analysis by Type of Media: 2012 VS 2020 VS 2027

Table 58: Japanese Demand Estimates and Forecasts for Contrast Media in US$ Thousand by Application: 2020 to 2027

Table 59: Japanese Contrast Media Market in US$ Thousand by Application: 2012-2019

Table 60: Contrast Media Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027

CHINA Table 61: Chinese Contrast Media Market Growth Prospects in US$ Thousand by Imaging Modality for the Period 2020-2027

Table 62: Contrast Media Historic Market Analysis in China in US$ Thousand by Imaging Modality: 2012-2019

Table 63: Chinese Contrast Media Market by Imaging Modality: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 64: Chinese Contrast Media Market Growth Prospects in US$ Thousand by Type of Media for the Period 2020-2027

Table 65: Contrast Media Historic Market Analysis in China in US$ Thousand by Type of Media: 2012-2019

Table 66: Chinese Contrast Media Market by Type of Media: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 67: Chinese Demand for Contrast Media in US$ Thousand by Application: 2020 to 2027

Table 68: Contrast Media Market Review in China in US$ Thousand by Application: 2012-2019

Table 69: Chinese Contrast Media Market Share Breakdown by Application: 2012 VS 2020 VS 2027

EUROPE Table 70: European Contrast Media Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027

Table 71: Contrast Media Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019

Table 72: European Contrast Media Market Share Shift by Region/Country: 2012 VS 2020 VS 2027

Table 73: European Contrast Media Market Estimates and Forecasts in US$ Thousand by Imaging Modality: 2020-2027

Table 74: Contrast Media Market in Europe in US$ Thousand by Imaging Modality: A Historic Review for the Period 2012-2019

Table 75: European Contrast Media Market Share Breakdown by Imaging Modality: 2012 VS 2020 VS 2027

Table 76: European Contrast Media Market Estimates and Forecasts in US$ Thousand by Type of Media: 2020-2027

Table 77: Contrast Media Market in Europe in US$ Thousand by Type of Media: A Historic Review for the Period 2012-2019

Table 78: European Contrast Media Market Share Breakdown by Type of Media: 2012 VS 2020 VS 2027

Table 79: European Contrast Media Addressable Market Opportunity in US$ Thousand by Application: 2020-2027

Table 80: Contrast Media Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2012-2019

Table 81: European Contrast Media Market Share Analysis by Application: 2012 VS 2020 VS 2027

FRANCE Table 82: Contrast Media Market in France by Imaging Modality: Estimates and Projections in US$ Thousand for the Period 2020-2027

Table 83: French Contrast Media Historic Market Scenario in US$ Thousand by Imaging Modality: 2012-2019

Table 84: French Contrast Media Market Share Analysis by Imaging Modality: 2012 VS 2020 VS 2027

Table 85: Contrast Media Market in France by Type of Media: Estimates and Projections in US$ Thousand for the Period 2020-2027

Table 86: French Contrast Media Historic Market Scenario in US$ Thousand by Type of Media: 2012-2019

Table 87: French Contrast Media Market Share Analysis by Type of Media: 2012 VS 2020 VS 2027

Table 88: Contrast Media Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027

Table 89: French Contrast Media Historic Market Review in US$ Thousand by Application: 2012-2019

Read the original here:
The global market for Contrast Media is projected to reach US$5.3 billion by 2025 - GlobeNewswire